Fintop-AF Spray
By Fintop-AF
50ml Solution in a Bottle

Composition
Amorolfine(0.25% w/v)

Manufacturer - Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.

Expires on or after
May, 2027

liver
When using Fintop-AF Spray, there are no known interactions or issues related to the liver. This means that the spray is not known to cause any harm or pose any risks specifically to the liver. It is important to note that no interactions have been found or established concerning the liver and Fintop-AF Spray.

kidney
Consult with your doctor for proper guidance before using Fintop-AF Spray.

alcohol
No interaction has been found or established between Fintop-AF Spray and alcohol. Use caution during pregnancy.

driving
When using Fintop-AF Spray, there is no known interaction affecting driving abilities.

pregnancy
Information on the safety of using Fintop-AF Spray during pregnancy is not available. It is advisable to consult your doctor before using this product.

breastfeeding
During breastfeeding, caution should be taken when using Fintop-AF Spray. It is advised to wait until the mother's treatment is finished and the drug is out of her system before resuming breastfeeding.
| Habit Forming | No |
| Chemical Class | Phenylpropane Derivative |
| Therapeutic Class | DERMA |
| Action Class | Antifungal Others |
₹350
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025
